Compugen Gets US FDA Approval for Solid Tumor Treatment Study-February 2024-www.financetom.com

Compugen Gets US FDA Approval for Solid Tumor Treatment Study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Compugen Gets US FDA Approval for Solid Tumor Treatment Study

Jul 29, 2024 8:56 AM

11:19 AM EDT, 07/29/2024 (MT Newswires) -- Compugen ( CGEN ) said Monday that the US Food and Drug Administration approved the company's investigational new drug application to start a phase 1 trial for COM503 as a potential treatment for patients with solid tumors.

The trial will evaluate COM503 as a monotherapy and in combination with Gilead Sciences' ( GILD ) zimberelimab in advanced solid tumors in Q4, Compugen ( CGEN ) said.

Compugen ( CGEN ) said it is now eligible to receive a $30 million milestone payment from Gilead for getting clearance from the FDA as part of their 2023 license agreement involving COM503.

Shares of Compugen ( CGEN ) were down 2.3% in recent trading.

Price: 1.73, Change: -0.04, Percent Change: -2.26

Previous page： Home Bancshares Insider Sold Shares Worth $3,302,200, According to a Recent SEC Filing Next page： Telus and FreeTelecom Partners to Launch Dual Mobile Service for Korean-Canadian Market

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Home Bancshares Insider Sold Shares Worth $3,302,200, According to a Recent SEC Filing

Aug 27, 2025

10:40 AM EDT, 08/27/2025 (MT Newswires) -- John W Allison, Director, Chairman and Chief Executive Officer, on August 26, 2025, sold 110,000 shares in Home Bancshares ( HOMB ) for $3,302,200. Following the Form 4 filing with the SEC, Allison has control over a total of 6,958,393 shares of the company, with 5,996,776 shares held directly and 961,617 controlled indirectly....

Telus and FreeTelecom Partners to Launch Dual Mobile Service for Korean-Canadian Market

Aug 27, 2025

10:39 AM EDT, 08/27/2025 (MT Newswires) -- TELUS ( TU ) (T.TO, TU) on Wednesday said it is partnering with FreeTelecom, a Korea budget telecommunications provider, to launch the FreeTelecom Dual Plan, what it calls an industry-first mobile solution. The company said the FreeTelecom Dual Plan allows customers to access both Korean and Canadian mobile services on a single device,...

Dynatrace Offers Valuation Increase Potential, Oppenheimer Says

Aug 27, 2025

10:38 AM EDT, 08/27/2025 (MT Newswires) -- Dynatrace ( DT ) could see an increase in its valuation as the catalysts are in place, Oppenheimer said in a Wednesday note. The report pointed to the potential for a meaningful uplift to revenue growth as its platform subscription pricing plan removes purchasing friction and drives multi-product adoption. Other catalysts include favorable...

Ryanair Reportedly Expects Boeing to Increase Production of 737 Jets

Aug 27, 2025

10:37 AM EDT, 08/27/2025 (MT Newswires) -- Ryanair ( RYAOF ) expects Boeing ( BA ) to increase its monthly production of 737 airplanes to 42 per month from 38 by October, Ryanair ( RYAOF ) Chief Executive Michael O'Leary told journalists in London on Wednesday, according to media reports. O'Leary said that he had spoken to Boeing ( BA...